CVS Health (NYSE:CVS) Stock: Insider Prem Shah Acquires 23,855 Shares

CVS Health Corporation (NYSE:CVS) EVP Prem Shah bought 23,855 shares of CVS Health stock in a transaction that occurred on Friday, November 6th. The stock was purchased at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the purchase, the executive vice president owned 88,516 shares of the company’s stock, valued at $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

CVS Health Trading Up 3.0%

Shares of CVS stock opened at $83.76 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The business has a 50-day moving average price of $90.37 and a two-hundred day moving average price of $88.89. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The firm has a market cap of $107.17 billion, a P/E ratio of 9.75, a price-to-earnings-growth ratio of 0.76 and a beta of 0.58.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.60 EPS. Equities analysts anticipate that CVS Health Corporation will post 8.25 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. CVS Health’s payout ratio is presently 30.97%.

Institutional Trading of CVS Health

Several hedge funds and other institutional investors have recently bought and sold shares of CVS. BlackRock Inc. bought a new stake in CVS Health during the 2nd quarter valued at $12,747,462,000. State Street Corp boosted its position in CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after buying an additional 15,604,883 shares during the period. Wellington Management Group LLP boosted its position in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after buying an additional 11,233,381 shares during the period. Bank of America Corp DE grew its holdings in CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after acquiring an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC bought a new stake in CVS Health in the 2nd quarter worth $1,217,558,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on CVS. UBS Group reduced their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday. Evercore restated an “outperform” rating on shares of CVS Health in a report on Wednesday. JPMorgan Chase & Co. upped their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Weiss Ratings lowered shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Finally, TD Cowen reiterated a “buy” rating on shares of CVS Health in a research report on Wednesday. Twenty-two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $108.25.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.